CytomX Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $260.9M
Liabilities Breakdown FY2022
Total Liabilities: $346.6M
Asset Breakdown
Total Assets: $260.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $193.7M | 74.2% |
| Accounts Receivable | $36.0M | 13.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.1M | 1.9% |
| Goodwill | $949.0K | 0.4% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $25.2M | 9.7% |
Liabilities Breakdown
Total Liabilities: $346.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.8M | 0.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $343.8M | 99.2% |